Accessibility settings

This paper is in the following e-collection/theme issue:

Applications of AI (1131) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (290) Chatbots and Conversational Agents (1256) Drug Repurposing and Off-Label Use (50) Generative Language Models Including ChatGPT (1676) AI Language Models in Health Care (862)

Published on in Vol 5 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/93862, first published .
Smartphone screen showing AI-driven research for Huntingtin's disease drug discovery

Conversational Multi-Agentic Network-Driven Disease Module Identification and Drug Repurposing Prediction With ChatDRex: Platform Development Study

Conversational Multi-Agentic Network-Driven Disease Module Identification and Drug Repurposing Prediction With ChatDRex: Platform Development Study

Authors of this article:

Simon Süwer1 Author Orcid Image ;   Kester Bagemihl1 Author Orcid Image ;   Sylvie Baier1, 2 Author Orcid Image ;   Lucia Dicunta1 Author Orcid Image ;   Markus List3, 4 Author Orcid Image ;   Jan Baumbach1, 5 Author Orcid Image ;   Fernando Miguel Delgado-Chaves1 Author Orcid Image ;   Andreas Maier1 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.